FilingIndex
10-KThe Record

Amylyx Pharmaceuticals, Inc. files 10-K

Filed Mar 3, 2026 · 3mo ago · Accession 0001193125-26-086645

Plain English

Annual report — full-year financials, business overview, and risk factors.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
AMLX
CIK
1658551
Form type
10-K
Filing date
Mar 3, 2026
Report date
Dec 31, 2025
Document
amlx-20251231.htm
Size
12.8 MB